SANUWAVE Health Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 98/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 54.00.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
SNWV's Score
Industry at a Glance
Industry Ranking
98 / 208
Overall Ranking
234 / 4578
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
54.000
Target Price
+80.72%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
SNWV Highlights
StrengthsRisks
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 94.92% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 32.63M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 32.63M.
Undervalued
The company’s latest PE is -60.01, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 4.71M shares, increasing 15.21% quarter-over-quarter.
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
Ticker SymbolSNWV
CompanySANUWAVE Health Inc
CEOFrank (Morgan C)
Websitehttps://sanuwave.com/
FAQs
What is the current price of SNWV (SNWV)?
The current price of SNWV (SNWV) is 31.020.
What is the symbol of SNWV?
The ticker symbol of SNWV is SNWV.
What is the 52-week high of SNWV?
The 52-week high of SNWV is 46.585.
What is the 52-week low of SNWV?
The 52-week low of SNWV is 20.500.
What is the market capitalization of SNWV?
The market capitalization of SNWV is 266.03M.
What is the net income of SNWV?
The net income of SNWV is -31.37M.
Is SNWV (SNWV) currently rated as Buy, Hold, or Sell?
According to analysts, SNWV (SNWV) has an overall rating of Buy, with a price target of 54.000.
What is the Earnings Per Share (EPS TTM) of SNWV (SNWV)?
The Earnings Per Share (EPS TTM) of SNWV (SNWV) is -0.517.